Ayotunde Omoz-Oarhe, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acquired Immunodeficiency Syndrome | 2 | 2023 | 2231 | 0.620 |
Why?
|
Isoniazid | 5 | 2024 | 273 | 0.480 |
Why?
|
Tuberculosis | 5 | 2024 | 1904 | 0.410 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2023 | 2026 | 0.410 |
Why?
|
HIV Infections | 9 | 2024 | 16678 | 0.390 |
Why?
|
Rifampin | 5 | 2022 | 315 | 0.330 |
Why?
|
Latent Tuberculosis | 2 | 2022 | 225 | 0.310 |
Why?
|
Antitubercular Agents | 5 | 2024 | 1319 | 0.210 |
Why?
|
Tuberculosis, Pulmonary | 2 | 2022 | 810 | 0.200 |
Why?
|
Alphapapillomavirus | 1 | 2022 | 221 | 0.170 |
Why?
|
Abortion, Spontaneous | 1 | 2024 | 542 | 0.160 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2022 | 385 | 0.160 |
Why?
|
Contraceptive Agents, Female | 1 | 2020 | 135 | 0.160 |
Why?
|
Anti-Retroviral Agents | 2 | 2023 | 1712 | 0.140 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2019 | 654 | 0.130 |
Why?
|
Premature Birth | 1 | 2024 | 1713 | 0.100 |
Why?
|
HIV | 3 | 2024 | 1600 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2022 | 1585 | 0.090 |
Why?
|
Nevirapine | 2 | 2022 | 267 | 0.090 |
Why?
|
Benzoxazines | 2 | 2022 | 301 | 0.090 |
Why?
|
Medroxyprogesterone Acetate | 2 | 2022 | 162 | 0.090 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2022 | 2011 | 0.090 |
Why?
|
Anti-HIV Agents | 2 | 2022 | 4250 | 0.080 |
Why?
|
Pregnancy | 3 | 2024 | 29087 | 0.070 |
Why?
|
Incidence | 1 | 2023 | 20928 | 0.070 |
Why?
|
Mass Screening | 2 | 2022 | 5238 | 0.050 |
Why?
|
Alkynes | 1 | 2022 | 306 | 0.050 |
Why?
|
Cyclopropanes | 1 | 2022 | 416 | 0.050 |
Why?
|
Adolescent | 3 | 2023 | 85649 | 0.050 |
Why?
|
Adult | 7 | 2023 | 213712 | 0.050 |
Why?
|
CD4 Lymphocyte Count | 2 | 2019 | 2557 | 0.050 |
Why?
|
Young Adult | 2 | 2023 | 56350 | 0.040 |
Why?
|
Pregnancy Trimester, First | 1 | 2024 | 851 | 0.040 |
Why?
|
Vaginal Smears | 1 | 2022 | 511 | 0.040 |
Why?
|
Africa | 1 | 2020 | 670 | 0.040 |
Why?
|
Female | 8 | 2024 | 379592 | 0.040 |
Why?
|
Pharmacogenetics | 1 | 2022 | 676 | 0.040 |
Why?
|
Drug Interactions | 1 | 2022 | 1458 | 0.040 |
Why?
|
Delayed-Action Preparations | 1 | 2020 | 965 | 0.040 |
Why?
|
Reference Standards | 1 | 2020 | 1020 | 0.040 |
Why?
|
Papillomaviridae | 1 | 2022 | 1118 | 0.030 |
Why?
|
Humans | 10 | 2024 | 742088 | 0.030 |
Why?
|
Pregnancy Outcome | 1 | 2024 | 2795 | 0.030 |
Why?
|
Sweating | 1 | 2013 | 123 | 0.030 |
Why?
|
Middle Aged | 2 | 2023 | 213127 | 0.030 |
Why?
|
Bacteriological Techniques | 1 | 2013 | 276 | 0.030 |
Why?
|
Male | 4 | 2023 | 349538 | 0.030 |
Why?
|
Prevalence | 2 | 2022 | 15194 | 0.020 |
Why?
|
Sputum | 1 | 2013 | 474 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 4929 | 0.020 |
Why?
|
Africa South of the Sahara | 1 | 2013 | 724 | 0.020 |
Why?
|
Peru | 1 | 2013 | 881 | 0.020 |
Why?
|
Cough | 1 | 2013 | 555 | 0.020 |
Why?
|
Standard of Care | 1 | 2013 | 562 | 0.020 |
Why?
|
Brazil | 1 | 2013 | 1263 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6483 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3070 | 0.020 |
Why?
|
Medication Adherence | 1 | 2019 | 2055 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 24913 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2013 | 1459 | 0.020 |
Why?
|
India | 1 | 2013 | 2187 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2013 | 1265 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2013 | 2699 | 0.020 |
Why?
|
Fever | 1 | 2013 | 1612 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2024 | 25575 | 0.010 |
Why?
|
Mycobacterium tuberculosis | 1 | 2013 | 1825 | 0.010 |
Why?
|
Infant | 1 | 2024 | 35070 | 0.010 |
Why?
|
Weight Loss | 1 | 2013 | 2604 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 40955 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15056 | 0.010 |
Why?
|
Child | 1 | 2022 | 77478 | 0.010 |
Why?
|
Algorithms | 1 | 2013 | 13853 | 0.010 |
Why?
|
Prospective Studies | 1 | 2013 | 53187 | 0.010 |
Why?
|
Aged | 1 | 2021 | 162944 | 0.010 |
Why?
|